Press releases | WebDisclosure

Basculer en Français

9559	Companies
188832	Keywords
120581	Articles
100785	Press releases

Home
Press releases

PRESS RELEASE

published on 09/30/2024 at 13:00, 1 year 2 months ago

Kaas Wilson Architects Expands Into Southwestern U.S. With Office in Phoenix, Arizona
Kaas Wilson Architects expands its national presence by opening a new office in Phoenix, Arizona, to better serve the southern and western U.S. regions, providing a wider range of services for multi-family housing clients

Office Expansion Kaas Wilson Architects Multi-family Architecture Phoenix Arizona National Growth
PRESS RELEASE

published on 09/30/2024 at 13:00, 1 year 2 months ago

Coaching.com Announces Leadership Transition: Alex Pascal Moves to Executive Chairman, Charlotte Saulny Appointed CEO.
Coaching.com announces strategic leadership transition, with Alex Pascal transitioning to Executive Chairman and Charlotte Saulny becoming CEO. Company positions for future growth

Leadership Transition Future Growth Coaching.com Alex Pascal Charlotte Saulny
PRESS RELEASE

published on 09/30/2024 at 13:00, 1 year 2 months ago

Electrovaya and Innovative Rail Technologies Enter into Strategic Supply Agreement for the Supply of Battery Systems for Electric Rail Applications
Electrovaya partners with IRT to supply Infinity battery systems for full electric locomotives, targeting rail applications in industrial operations, ports, short line railroads, defense, and commuter rail

Electrovaya Battery Systems Rail Applications IRT Electric Locomotives
PRESS RELEASE

published on 09/30/2024 at 13:00, 1 year 2 months ago

Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
Tharimmune, Inc. and Intract Pharma to merge, creating transformative oral biologics company. Merger expected to enhance pipeline growth, innovation, and patient outcomes in the biologics market

Merger Tharimmune Intract Pharma Oral Biologics Pipeline Growth
PRESS RELEASE

published on 09/30/2024 at 13:00, 1 year 2 months ago

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
Moderna initiates Phase 3 trial for mRNA-1403, an investigational norovirus vaccine, aiming to prevent infection from norovirus. Global recruitment has started

Moderna Phase 3 Trial MRNA-1403 Norovirus Vaccine Global Recruitment
PRESS RELEASE

published on 09/30/2024 at 13:00, 1 year 2 months ago

Significant Metallurgical Advancement: Moving Toward a New Industry Standard for LiFePO4 Battery Feedstock
St-Georges Metallurgy Corp., a leader in mineral processing technologies, advances lithium processing with a novel one-step LiFePO4 production process. Collaboration with partners aims for cost-effective battery feedstock production and environmental sustainability

Environmental Sustainability Lithium Processing St-Georges Metallurgy Corp. LiFePO4 Production Battery Feedstock
PRESS RELEASE

published on 09/30/2024 at 12:48, 1 year 2 months ago

EQS-Adhoc: Blue Cap AG sells subsidiary nokra to Vishal Precision Group
Blue Cap AG sells nokra to Vishal Precision Group, generating single-digit million proceeds. Agreement includes 90% stake sale and 6x capital employed multiple

Blue Cap AG Sale Proceeds Nokra Vishal Precision Group
PRESS RELEASE

published on 09/30/2024 at 12:40, 1 year 2 months ago

Photon Energy to Run FORVIA’s First On-Site PPA Solar Power Plant in Hungary
Photon Energy completes construction of 658 kWp solar power plant in Hungary under PPA with FORVIA's Clarion Hungary, contributing to reduced CO2 emissions and long-term energy cost savings

Photon Energy PPA Solar Power Plant Hungary Forvia
PRESS RELEASE

published on 09/30/2024 at 12:30, 1 year 2 months ago

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID
NanoViricides, Inc. reports filing of Annual Report on Form 10-K for fiscal year 2024, financial updates, and plans for Phase II clinical trials of antiviral drug NV-387

NanoViricides NV-387 Financial Updates Form 10-K Phase II Clinical Trials
REGULATED PRESS RELEASE

published on 09/30/2024 at 12:05, 1 year 2 months ago

Statement of transactions in own shares from September 23, 2024 to September 27, 2024

Accesswire

Published on 12/19/2025 at 22:00, 2 hours 4 minutes ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 5 hours 34 minutes ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 9 hours 24 minutes ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 10 hours 34 minutes ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 10 hours 34 minutes ago

DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition

View all ACCESSWIRE

EQS Group

Published on 12/19/2025 at 22:03, 2 hours 1 minute ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 2 hours 24 minutes ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 3 hours 29 minutes ago

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 20:15, 3 hours 49 minutes ago

CSDS EU RNS Name Changes (19 December 2025)
Published on 12/19/2025 at 19:56, 4 hours 8 minutes ago

Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy

Les Echos

Published on 12/19/2025 at 21:57, 2 hours 7 minutes ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 15 hours 34 minutes ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 15 hours 34 minutes ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 17 hours 4 minutes ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 17 hours 4 minutes ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE